chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sensitivity to light; Nausea; Muscle Pain; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PHOTOPHOBIA (Sensitivity to light), NAUSEA (Nausea), MYALGIA (Muscle Pain) and PYREXIA (Fever) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure abnormal. Concomitant products included PREGABALIN for Anesthetic complication neurological, DULOXETINE for Antidepressant therapy, PROPRANOLOL for Blood pressure.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced PHOTOPHOBIA (Sensitivity to light), NAUSEA (Nausea), MYALGIA (Muscle Pain) and PYREXIA (Fever). At the time of the report, PHOTOPHOBIA (Sensitivity to light), NAUSEA (Nausea), MYALGIA (Muscle Pain) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment product information was provided.
1/28/21, 2 hrs post vaccine: vaginal bleeding started, ended 3/12/21 despite continuing dura apri birth control daily. Last menstrual period was 6 days in June 2019. Birth control placebos are skipped to deter menstruation d/t endometriosis. 12 hrs post vaccine: nausea, diarrhea, migraine, low-grade fever (99.8), body aches and chills. Lasted 36 hrs post vaccine. On 2/3/21, I developed thrombosed hemorrhoids that didn't resolve until 2/26/21. Mild headaches daily until 3/12/21. Headaches continue to occur 4-7 days/wk to date. Other effects post vaccine continuing to date: constant mild-moderate aching in right wrist and elbow, daily severe fatigue, brain fog, dry eyes/mouth, eyesight deterioration (I have to get a revision on my lasik surgery)
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 64-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 22Sep2022 as dose 5 (booster), single (Lot number: G49703), in right arm and on 18Jun2023 as dose 6 (booster), single (Lot number: GK9276), in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 02Mar2021 as dose 1, single (Lot number: EN6202), in left arm, on 23Mar2021 as dose 2, single (Lot number: EP7534), in right arm, on 01Oct2021 as dose 3 (booster), single (Lot number: 30155BA), in left arm and on 06Apr2022 as dose 4 (booster), single (Lot number: FJ5668), in left arm for covid-19 immunisation. The patient's relevant medical history included: "diabetes Type 2" (unspecified if ongoing), notes: Other medical history: diabetes Type 2. The patient's concomitant medications were not reported. Past drug history included: Jardiance, reaction(s): "Known Allergies: Jardiance", notes: Known Allergies: Jardiance. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of vaccination failure, covid-19 which included Paxlovid.
On 22Jul2020, /received first / dose / did not return / to receive the second dose; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 70-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The pharmacist stated that, the patient received first Shingrix dose, however did not return within the recommended time frame to receive the second dose. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter consented to follow up.
myalgia, fatigue, and skin sensitivity in hip and leg on left side has persisted for 7 days
stomach pain; face breaking out; This is a spontaneous report from a consumer (patient father). This consumer reported for 25 years old female patient(daughter). A 25 years and 11 months old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date were not reported), via an unspecified route of administration on an unspecified date as single dose for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that the patient had first dose of the vaccine three weeks ago and had a very bad reaction to it. She had quite bad stomach pain for about three weeks, face breaking out and is not willing to get the second shot. Patient father wanted to know the efficacy of the first dose and how long will it last and if his daughter changes her mind, is the recommended interval between the first dose and second dose. He is asking if his daughter can get the Johnson & Johnson COVID Vaccine. Patient second dose was in the middle of this month (15 th). The outcome of the events was unknown.  Information about batch/Lot number has been requested.
Fever for 3 days, malaise, poor appetite developed fluid filled vesicles and smaller papules.
Saturday 3/27/2021 -After waiting 15 minutes after the shot, my leg and arm affected with my MS became heavy and not very responsive.  This only lasted for 2-3 hours and I was able to walk and hold things. Sunday 3/28/2021 - I experienced pain in my joints and body most of the day.  At about 5:00pm,  I had chills, headache and extreme pain everywhere.  I could no longer could use my leg and arm (MS limbs).   My chest felt heavy and tight when breathing.  I used Tylenol and Ibuprofen intermittently and drank lots of water.  Slept most of the day.   Monday 3/29/2021 Woke up  with a headache, some pain in my joints and not able walk without difficulty until 2:30pm, after that time I  was able to walk short distances slowly. Tuesday 3/30/2021 -At work, moving slow but feeling better.
Patient developed erythematous rash at injection site over 1 month later. Says that rash was tender and warm. Resolved in 5-7 days. Did not seek medical attention. Notified my office 2 months after injection.
Information has been received from a 47 year old female patient who was participated in a Market research program. Concurrent condition and medical history were not reported. On an unknown date the patient was vaccinated with a dose of pneumococcal vaccine ((reported as "Pneumonia/pneumococcal (disease) vaccine, manufacturer unknown)) (lot#, expiration date, route and dose were unknown). Concomitant therapies were not reported. It was reported that the patient "previously ended up hospitalized with pneumonia after having the vaccine". The outcome of the event was unknown. Additional information has been requested.
I had a scratchy throat that made me hoarse. I had a slight runny nose. The next day I took an at home COVID-19  test that was positive. A couple days later I went in to the pharmacy with my Wife and took a COVID-19 test that came back positive. I had a telephone visit with a doctor and was prescribed Paxlovid for 5 days.   My symptoms lasted about 4-5 days. I felt the worse on the third day, and after that it started to clear up.
Headaches, arthritis worse, sore throat, cough, dizziness and massive bladder infections. Increase in seizures too.
Irregular fluttering heartbeat lasting 15-20 seconds, multiple occurrences. Has never happened before.
The patient fainted after 5 min from administring; no BLS needed, woke up in less than 1 min no epinephrine needed
soreness at injection; This is a spontaneous report from a contactable consumer based on information received by Pfizer from agency (manufacturer control number: EC-2020-083296).  A 76-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date as a single dose for COVID-19 immunization. Relevant history includes endometrial carcinoma, pembrolizumab (KEYTRUDA) infusions. Patient continues to take Lenvima 10 mg once daily. Stated "I'm doing okay with it." Received second COVID vaccine (Pfizer) and noted with soreness at injection site. Diagnosis Endometrial carcinoma, Lenvima 20 mg once daily, start date 11/2/20 and temporary stop date 11/6/20 and resumed Lenvima 14 mg once daily on 11/9/20, stopped Lenvima 14 mg once daily temporarily for one week and resumed Lenvima 10 mg once daily on 12/26/20, stopped Lenvima temporarily for 10 days and resumed Lenvima 10 mg on 1/31/21. The clinical outcome of soreness at injection site was unknown.   Follow-up attempts completed. No further information expected. Information about lot number cannot be obtained.
Flare up of pre-existing autoimmune condition causing painful, swollen, and stiff joints, fatigue, headaches, nausea, abdominal cramping, and alternating diarrhea and constipation.
nausea; threw up last night throw up generally unwell; generally unwell; This is a spontaneous report received from a contactable reporter (Consumer) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 13Mar2021 17:00 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious) with onset 15Mar2021, outcome "unknown", described as "nausea"; VOMITING (non-serious) with onset 15Mar2021, outcome "unknown", described as "threw up last night throw up generally unwell"; MALAISE (non-serious) with onset 15Mar2021, outcome "unknown", described as "generally unwell".  No follow-up attempts are possible. No further information is expected.
Patient complained of mild/moderate pain in the middle of her back that was radiating up her neck within 10 minutes of vaccination.  Patient waited a full 15 minutes in waiting area post vaccination and left the store.  Patient was contacted 6 hours later to follow up and pain had resolved without medication or intervention.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (159558). A 83 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "Seniors who take the vaccine are 80% effective and don't have to take the second shot"; ILLNESS (non-serious), outcome "unknown", described as "both got very sick/Got so sick".  Additional Context: This is the second case out of two cases. Reporter stated, "They telling everybody to go and get vaccinated (Unspecified vaccine) so I had cousin of mine who is in her 70's, she went to get vaccinated and I also took my mother who is 83 years old and I had her vaccinated and they both got the Pfizer vaccination. They went to the first one and the 2 of them got so sick, so I am afraid to take my mother to the second dose now in April. Somebody told me that senior citizens when you get the first dose they were 80 percent something, they don't have to get the second shot, is that true, with the Pfizer. It's terrible they telling people to get vaccinated, people getting sick. What's the phone number, I got the news to you, and I am going to think twice now and getting the vaccine, seeing how my mother is".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Information has been received from a lawyer on regarding a case in litigation concerning a female patient of unknown age. No information was provided regarding the patient's past medical history, concurrent condition, or concomitant medication. The patient was inoculated with ZOSTAVAX vaccine (lot number not reported) on unknown date at a pharmacy as recommended for routine adult health maintenance for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 01-JAN-2016, the patient was treated by a physician for a painful vesicular rash that was diagnosed as shingles. On or about 02-JAN-2016, the patient was treated for ongoing and worsening herpes zoster symptoms. On or about 28-MAR-2016 the patient was treated by a physician for conditions identified as postherpeutic neuralgia, a chronic condition of nerve pain and damage as a residual effect of severe shingles. On or about 13-OCT-2016 was seen at emergency room for new and worsening shingles. For the spectrum of her painful symptoms the patient was prescribed gabapentin and acyclovir to manage and attempt to mitigate her outbreaks. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the shingles is unknown. Additional information has been requested.
Eleven (11) days after receiving the first dose of the Moderna Vaccine, My upper left arm showed signs of a rash.  I've been keeping an eye on it and showed my arm to my doctor on Wednesday, January 13 2021.  At that time Dr.  stated that it was a reaction to the Moderna Vaccine.  As of today (1/14/2021), the rash appears to be spreading across my upper left arm.  I am applying icepacks in the evening at home.
Baseball size red & warmth at injection site - ZYRTEC, BENADRYL, ice & KEFLEX.
TORE RIGHT LEG MUSCLE AND RIGHT ARM MUSCLE; BLACKENED RIGHT ARM AND RIGHT LEG; This spontaneous report received from a patient concerned a 69 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A, expiry: unknown) dose was not reported, 1 total, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 20-APR-2021, the patient experienced tore in a muscle in the right leg that turned black while getting off the couch and the blackened right arm leg was covered from the knee down. The patient went to the hospital for evaluation. It was concluded that it was not a blood clot.  On 27-APR-2021, the patient experienced tore in a muscle in the right arm which also turned black and the blackened right arm extended from the shoulder to the wrist down. Medical providers indicated it was not a blood clot. The patient right leg and arm was healed in 6 and 4 weeks. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tore right leg muscle and right arm muscle and blackened right arm extended from the shoulder to the wrist down on to blackened right arm and right leg 01-JUN-2021. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210727926- Covid-19 vaccine ad26.cov2.s- tore right leg muscle and right arm muscle. This event is considered unassessable. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.
Low grade fever. Slept constantly for 2 days. Awakens briefly to eat then back to sleep.
Surveillance for Rates of Pertussis Disease Among Persons Birth through 59 months of Age Receiving PENTACEL or Other Pertussis Vaccines. Subject ID # 411455. Initial report received on 11 January 2011 from the Investigator participating in the above-mentioned post-marketing observational surveillance study under the reference number M5A16. This is one case in a series of 11 Pertussis cases received during the surveillance period from 01 January 2010 to 11 January 2011. A case of Pertussis disease in a 4-year-old female subject (initials not collected) was identified by the investigator based on review of data from the Electronic Disease Surveillance System. The subject's vaccine history included 4 doses of DAPACEL; lot number CT06AA received on 19 May 2006, lot number CT06AA received on 21 July 2006, lot number C2649AA on 15 September 2006, and lot number C62651AA on 15 June 2007. On 16 July 2010, approximately three years after the last dose, the subject developed a paroxysmal cough. She also experienced symptoms of posttussive vomiting and sleep disturbance (onset dates not reported). It is unknown if she experienced symptoms of catarrhal illness. Laboratory testing included positive PCR (date not reported). Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of AZITHROMYCIN starting on 04 August 2010 ( stop date not reported). The subject was not hospitalized. At the time of final contact on 14 September 2010, the subject's cough had been resolved. The total duration of the cough was reported at that time as 46 days. Investigator causality assessment not required as per protocol. Documents held by sender: None.
chills; muscle spasms; every bone hurt; nausea; vomiting; fatigue; frequent urination; This is a spontaneous report from a contactable consumer. A 74-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection, Batch/Lot Number: EN9581), via an unspecified route of administration, administered in Arm Left on 08Feb2021 09:45 as single dose for covid-19 immunisation at hospital. Medical history included drug hypersensitivity (Penicillin) from an unknown date and unknown if ongoing. The historical vaccine included patient's first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE: Solution for injection, Batch/Lot Number: EL3249), via an unspecified route of administration, administered in Arm Left on 21Jan2021 05:30 PM, as single dose for covid-19 immunisation. Concomitant medication included atorvastatin calcium, 20 mg and lisinopril 10mg. On 09Feb2021 12:30, the patient experienced chills, muscle spasms, every bone hurt, nausea, vomiting, fatigue, frequent urination. The action taken in response to the event for BNT162B2 was not applicable. The outcome of event was recovering.
I received the Pfizer vaccine on November 12. A day after I received the vaccine I started noticing some chest pains and heart palpitations. Each day that passed I noticed they were getting a little bit stronger. On the 18th I woke up with severe chest pain, SOB, fever, cough. The pain was so bad I started to vomit. Just couldn?t seem to catch my breath at all. Went to the ER and my pulse ranged anywhere from 112-146 .
within 24 hours began with very itchy rash primarily to her thighs, abdomen, back and chest
Immediate sharp pain in left neck and shoulder area. Have had a swollen lymph node in armpit since first shot. The pain in neck and arm occurred immediately when jab of 2nd shot given April 21st. Have experienced increased pain in under arm lymph nodes and in July the shoulder pain became excruciating. I made appointment with PCP who ordered ultrasound of armpit and mammogram. My chiropractor  ordered a shoulder x-ray which I had on July 19th, structure looks good. Am scheduled for the ultrasound/mammogram Aug 25th. Left shoulder continues to throb and ache as well as armpit pain.
Persistent and severe pain L arm with shoulder/deltoid weakness over greater than 2 weeks.
The evening after the vaccines she had different (high pitched cry) inconsolable, Tylenol given and did not help.  Lasted approximately 2-3 hours.  Her left leg was swollen red warm to the touch and was a dark purple color.  The second day she cried more.  Mother reports it "took about three days for her to stop crying"
- Pt developed swelling of and erythema around injection site on right thigh. Swelling at maximum ~ 5 inches by 4 inches on 8-7-09. Erythema began to improve on 8-8-09. Only local ice was applied. No other treatment.
None. Patient received PCV 13 in error, should have received PPV 23. Elt tobacco use.
5-11 Covid vaccine not diluted. 0.2mL of undiluted vaccine administered to left arm. After drawing 5 doses LVN noticed there was not sufficient amount left for 10 doses. LVN realized the vial was not diluted. MD notified
My father had the booster shot for Covid-19 on Sunday. Thursday morning following the booster, he suddenly lost his left eye vision completely. He went to see an eye specialist immediately and they said it was due to inflammation. He is taking anti-inflammatory prednisone since then, but the vision is still gone.
PT is a 15y/o M who obtained moderna vaccine on 10/20/2021 at 4:27pm. Despite PT being under age for vaccination he demonstrated good tolerance. He remained stable in office post vaccination. No adverse reaction or intolerance to injection. PT was observed for 15mins.
Patient complained of sick to stomach arm swollen and red in 3-4 different areas.  Tender under arm.
Information has been received from a lawyer regarding a case in litigation concerning a male patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 18-AUG-2016, the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) for routine adult health maintenance and the intended purpose of the long-term prevention of shingles and zoster-related injuries. Upon information and belief, on or about 18-AUG-2016, a physician, recommended and/or administered the ZOSTAVAX vaccine to the patient for its intended purpose of long-term prevention of shingles and zoster-related injuries. The vaccine did not prevent shingles or zoster-related injuries as intended. On or about 31-AUG-2016, the patient was treated by a physician for herpes zoster, or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles and zoster-related injuries, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Redness at injection site, redness moving down arm, diarrhea, soreness at injection site.
I21.4 - NSTEMI (non-ST elevated myocardial infarction) (CMS/HCC) N17.9 - Acute renal injury (CMS/HCC)
pt recvd vax 16AUG95 & 25AUG95 pt devel a sore mouth, became itchy, had h/a & was sweating;No further details were provided;